Comment
Risks, Regulation, and Rewards in New Drug Development in the United States

https://doi.org/10.1006/rtph.1994.1021Get rights and content

First page preview

First page preview
Click to open first page preview

References (0)

Cited by (25)

  • Atom-based non-stochastic and stochastic bilinear indices: Application to QSPR/QSAR studies of organic compounds

    2008, Chemical Physics Letters
    Citation Excerpt :

    The development of a new chemical entity (NCE) with biological activity, using traditional methods, is a time consuming and expensive process [1].

  • Industry or academia: Who leads the research in medicine?

    2007, European Journal of Internal Medicine
View all citing articles on Scopus
View full text